Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Wang Yusheng

Clinical trials sponsored by Wang Yusheng, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a lower dose of an eye drug protect preterm Infants' sight? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Can a lower dose of an eye drug protect preterm Infants' sight?

Disease control Recruiting now

This trial investigates whether a low dose of the drug conbercept can effectively treat retinopathy of prematurity (ROP), an eye disease that can cause blindness in preterm infants. The study will enroll 146 preterm babies with type 1 ROP and compare the low-dose treatment agains…

Sponsor: Wang Yusheng • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC